Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study Comparing Anrikefon With Nalfurafine in Improving Sleep Quality Among CKD-aP Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Clinical Trial

NCT07380113 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT07380113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07380113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study Comparing Anrikefon With Nalfurafine in Improving Sleep Quality Among CKD-aP Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Clinical Trial
Lead sponsor
Zhujiang Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
June 22, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases, chronic, pruritus chronic, pruritus due to hemodialysis, pruritus due to systemic disorder (disorder), renal insufficiency, chronic, uremia; chronic